Sreepathi Pharmaceuticals Limited, a active public limited company, was established on 29 December 1983 in Telangana, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24239TG1983PLC004356. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹4.20 Cr and a paid-up capital of ₹3.70 Cr.
It upholds a compliant status. Employing 119 professional, Its leadership includes Srinivas Isola (Managing Director), Satya Isola Akhil (Director), Karthik Isola Chandra (Director). Past directors included Pawan Kumar Agrawall, Ramachandra Mantha Rao, Peri Srinivasa Sharma. It holds ₹70.24 Cr open charges and ₹46.68 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot.No.22B, H.No.8-2-293/82/A/22/B, Road.No.2, Jubilee Hills,, Telangana, Telangana, 500033.
U24239TG1983PLC004356
004356
29 December 1983
₹4.20 Cr
₹3.70 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Sreepathi Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Srinivas Isola | Managing Director | 09 Mar 2006 | Current |
| Satya Isola Akhil | Director | 27 Aug 2009 | Current |
| Karthik Isola Chandra | Director | 04 Jul 2018 | Current |
| Shyamala Isola | Whole-Time Director | 08 Apr 2006 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 05 Oct 2009 | Past |
| Pramod Abcsdd | Director | 03 Jul 2018 | Past |
| Pramod Abcsdd | Director | 03 Jul 2018 | Past |
| Pramod Abcsdd | Director | 05 Mar 2016 | Past |
| Pramod Abcsdd | Director | 03 Jul 2018 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sreepathi Pharmaceuticals Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 0.95% increase. The company also saw a substantial improvement in profitability, with a 1040.7% increase in profit. The company's net worth moved up by a moderate rise of 1.55%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Sreepathi Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹702,414,000.00
₹466,800,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Sep 2018 | Yes Bank Limited | ₹29.75 Cr | Open |
| 03 Nov 2015 | Hdfc Bank Limited | ₹40.49 Cr | Open |
| 19 Nov 2015 | The Hongkong And Shanghai Banking Corporation Limited | ₹1.20 Cr | Satisfied |
| 19 Nov 2015 | The Hongkong And Shanghai Banking Corporation Limited | ₹17.00 Cr | Satisfied |
| 12 Apr 1997 | State Bank Of Hyderabad | ₹4.80 M | Satisfied |
Explore comprehensive loan charge details -
Sreepathi Pharmaceuticals has a workforce of 119 employees as of Aug 11, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sreepathi Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sreepathi Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Sreepathi Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Sreepathi Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
A charge with Hdfc Bank Limited of Rs. 40.49 Cr registered on 03 Nov 2015 with Charge ID 10603731 was modified on 05 Mar 2024. was recorded as a recent event.
A charge with Yes Bank Limited of Rs. 29.75 Cr registered on 28 Sep 2018 with Charge ID 100214542 was modified on 22 Sep 2022. was recorded as a recent event.
Progress on A charge registered on 19 Nov 2015 via Charge ID 10604186 with The Hongkong And Shanghai Banking Corporation Limited was fully satisfied on 04 Feb 2019. was documented.
The activity A charge registered on 19 Nov 2015 via Charge ID 10604209 with The Hongkong And Shanghai Banking Corporation Limited was fully satisfied on 04 Feb 2019. was completed.
The CIN of Sreepathi Pharmaceuticals Limited is U24239TG1983PLC004356.
Sreepathi Pharmaceuticals Limited is headquartered at Plot.No.22B, H.No.8-2-293/82/A/22/B, Road.No.2, Jubilee Hills,, Telangana, Telangana, 500033.
Sreepathi Pharmaceuticals Limited was incorporated on 29 December 1983.
The current directors of Sreepathi Pharmaceuticals Limited are
The primary industry of Sreepathi Pharmaceuticals Limited is Manufacturing.
Sreepathi Pharmaceuticals Limited is unlisted.
The authorized capital of Sreepathi Pharmaceuticals Limited is ₹4.20 Cr, and the paid-up capital is ₹3.70 Cr.
The compliance status of Sreepathi Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX